Perry Premdas
Director/Board Member at OPX Biotechnologies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Theodore Harris | M | 59 | 9 years | |
| John Robert Ducker | M | 64 |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 14 years |
| Daniel Knutson | M | 67 | 6 years | |
| Teresa Cook | F | - | 19 years | |
| Matthew Wineinger | M | 57 | 9 years | |
| Hatsuki Miyata | F | - | 2 years | |
| Michael D. Lynch | M | - |
OPX Biotechnologies, Inc.
 OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 17 years |
| Martin Bengtsson | M | 47 | 5 years | |
| Joyce Lee | F | 51 | 5 years | |
| Kathleen Fish | F | 66 | 3 years | |
| David Fischer | M | 61 | 14 years | |
| Jon Feiber | M | 67 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Brian Dunn | M | 62 | 12 years | |
| Martin Reid | M | 57 | 3 years | |
| Michael Sestrick | M | 61 | 7 years | |
| Steve Polo | M | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Brent Tignor | M | - | 8 years | |
| Dirk McDermott | M | 68 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Gerrit Steen | M | 53 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 14 years |
| Scott W. Meacham | M | 64 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 15 years |
| Jonathan Koch | M | 54 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Steven Foster | M | 62 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Jonathan Griffin | M | - | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dino Rossi | M | 69 | 20 years | |
| James Standen | M | 49 | 18 years | |
| Francis J. Fitzpatrick | M | 63 | 20 years | |
| Angelo C. Brisimitzakis | M | 65 | 6 years | |
| Francis Malecha | M | 60 | 5 years | |
| Michael Ducey | M | 75 | 4 years | |
| John D. Craft | M | - | 2 years | |
| Rodney L. Underdown | M | 57 | 13 years | |
| Charles Eggert | M | 70 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 6 years |
| Matthew David Houston | M | 60 | 12 years | |
| Amy Yoder | F | 56 | - | |
| Paul D. Coombs | M | 68 | 11 years | |
| John Televantos | M | 71 | 18 years | |
| Robert Chess | M | 66 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 8 years |
| Allan Rothwell | M | 76 | 16 years | |
| Timothy Snider | M | 73 | 5 years | |
| Dennis Bergeson | M | - | 11 years | |
| Stephen P. Toon | M | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 4 years |
| Steven N. Berger | M | 58 | - | |
| Eric Ford | M | 69 | 12 years | |
| Elaine Wedral | M | 80 | 11 years | |
| Paul Williams | M | 63 | 14 years | |
| Edward McMillan | M | 77 | 15 years | |
| Mary Coelho | F | 62 | 1 years | |
| Mark A. Stach | M | 62 | - | |
| Jack C. Leunig | M | 70 | 9 years | |
| Christopher Bryant | M | 62 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 4 years |
| Peter Perry Copses | M | 65 | 2 years | |
| Jerry A. Smith | M | - | 11 years | |
| Hendrik Meerman | M | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 3 years |
| Shelly L. Kinnune | F | 53 | - | |
| Val Gene Romberg | M | 66 |
Centeon LLC
| - |
| Robert Dana Miller | M | 66 | 3 years | |
| Akash Tayal | M | - | 9 years | |
| Richard G. Ganz | M | 66 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 1 years |
| Theresa L. Womble | F | - | 10 years | |
| James Wolf | M | - | - | |
| Hans Liao | M | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 5 years |
| Surendera Tyagi | M | - |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | - |
| Dana E. Putnam | M | - | - | |
| John E. Kuehner | M | - | 12 years | |
| Jerry Bucan | M | - | - | |
| Frank Löhner | M | 59 |
Celanese AG
 Celanese AG Chemicals: Major DiversifiedProcess Industries Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany. | 1 years |
| Elizabeth Anderson | F | 66 |
Centeon LLC
| 4 years |
| Tara Hart Hefner | F | - | - | |
| Jeff McCartney | M | - | 20 years | |
| Matthew Foulston | M | 60 | 2 years | |
| Claudio Thomaz Lobo Sonder | M | 82 |
Celanese AG
Celanese AG Chemicals: Major DiversifiedProcess Industries Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany. | 5 years |
| Richard Allen Bendure | M | 55 | 2 years | |
| Hoyt Ammidon | M | 86 | 7 years | |
| Heinn F. Tomfohrde | M | 90 | 3 years | |
| Scott C. Mason | M | 65 | 3 years | |
| William Barnhart | M | 81 |
Centeon LLC
| 2 years |
| Vernon G. Baker | M | 70 | 3 years | |
| Keith E. Clark | M | 68 | 18 years | |
| David J. Goadby | M | 69 | - | |
| Daniel Muehl | M | 61 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 4 years |
| John S. Fallis | M | 76 | 3 years | |
| Ronald Bryan | M | 71 | 9 years | |
| Paul H. Richardson | M | 54 | 10 years | |
| Gerald Bucan | M | 60 | 6 years | |
| Thomas H. Silberg | M | 76 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 3 years |
| Kenneth P. Mitchell | M | 84 | 17 years | |
| David A. Hogsett | M | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 2 years |
| David F. Ludwig | M | 66 | 20 years | |
| Alfred W. Langer | M | 73 |
Celanese AG
Celanese AG Chemicals: Major DiversifiedProcess Industries Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany. | 2 years |
| Giulio A. Perillo | M | 77 |
Centeon LLC
| 3 years |
| David N. Weidman | M | 68 |
Celanese AG
Celanese AG Chemicals: Major DiversifiedProcess Industries Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany. | 4 years |
| Andreas Pohlmann | M | 65 |
Celanese AG
Celanese AG Chemicals: Major DiversifiedProcess Industries Celanese AG is a producer of acetyl products, including acetic acid, vinyl acetate monomer (VAM), polyacetal products (POM), as well as engineered polymers used in consumer and industrial products designed to meet technical customer requirements. It is a subsidiary of Celanese Corp. and headquartered in Kronberg, Germany. | 5 years |
| Bernhard Hampl | M | 75 |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | 2 years |
| Barbara E. Baring | F | - |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 6 years |
| John R. Stevenson | M | - | 1 years | |
| James Hyde | M | 64 | - | |
| Keith E. Espelien | M | 64 | 5 years | |
| Earl Douglas | M | 61 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | 3 years |
| Nancy Pfund | F | 68 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO. | - |
| Aisha Reynolds | F | 47 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Germany | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Perry Premdas
- Personal Network